B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PRMT6

MOLECULAR TARGET

protein arginine methyltransferase 6

UniProt: Q96LA8NCBI Gene: 551701 compounds

PRMT6 (protein arginine methyltransferase 6) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PRMT6

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine0.691

About PRMT6 as a Drug Target

PRMT6 (protein arginine methyltransferase 6) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented PRMT6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PRMT6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.